Dynamic Technology Lab Private Ltd Buys Shares of 18,642 Maximus, Inc. $MMS

Dynamic Technology Lab Private Ltd bought a new stake in Maximus, Inc. (NYSE:MMS) in the 4th quarter, Holdings Channel reports. The institutional investor bought 18,642 shares of the health services provider’s stock, valued at approximately $1,609,000.

Several other large investors have also recently bought and sold shares of MMS. Richardson Financial Services Inc. boosted its position in shares of Maximus by 29.6% during the fourth quarter. Richardson Financial Services Inc. now owns 451 shares of the health services provider’s stock valued at $39,000 after buying an additional 103 shares during the last quarter. Farther Finance Advisors LLC boosted its position in shares of Maximus by 69.0% during the fourth quarter. Farther Finance Advisors LLC now owns 284 shares of the health services provider’s stock valued at $25,000 after buying an additional 116 shares during the last quarter. GAMMA Investing LLC boosted its position in shares of Maximus by 13.8% during the fourth quarter. GAMMA Investing LLC now owns 1,522 shares of the health services provider’s stock valued at $131,000 after buying an additional 185 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its position in shares of Maximus by 0.6% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 34,476 shares of the health services provider’s stock valued at $2,351,000 after buying an additional 221 shares during the last quarter. Finally, Larson Financial Group LLC boosted its position in shares of Maximus by 13.8% during the third quarter. Larson Financial Group LLC now owns 1,869 shares of the health services provider’s stock valued at $171,000 after buying an additional 227 shares during the last quarter. 97.21% of the stock is currently owned by institutional investors.

Maximus Stock Up 0.6%

Shares of NYSE MMS opened at $62.36 on Friday. Maximus, Inc. has a one year low of $56.92 and a one year high of $100.00. The company has a debt-to-equity ratio of 0.87, a current ratio of 2.21 and a quick ratio of 2.21. The business’s fifty day moving average price is $63.46 and its 200-day moving average price is $75.94. The stock has a market capitalization of $3.28 billion, a PE ratio of 9.34 and a beta of 0.58.

Maximus (NYSE:MMS) last issued its quarterly earnings results on Thursday, May 7th. The health services provider reported $2.07 EPS for the quarter, beating analysts’ consensus estimates of $1.98 by $0.09. Maximus had a return on equity of 25.10% and a net margin of 7.02%.The firm had revenue of $1.31 billion for the quarter, compared to analysts’ expectations of $1.32 billion. During the same quarter in the prior year, the firm earned $2.01 EPS. The business’s revenue for the quarter was down 4.1% compared to the same quarter last year. Maximus has set its FY 2026 guidance at 8.250-8.550 EPS. On average, equities research analysts anticipate that Maximus, Inc. will post 8.43 EPS for the current year.

Maximus Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Monday, June 1st. Investors of record on Friday, May 15th were paid a dividend of $0.33 per share. This represents a $1.32 dividend on an annualized basis and a dividend yield of 2.1%. The ex-dividend date was Friday, May 15th. Maximus’s payout ratio is presently 19.76%.

Insider Activity

In related news, Director Jan Madsen sold 742 shares of the business’s stock in a transaction on Tuesday, March 17th. The stock was sold at an average price of $72.25, for a total transaction of $53,609.50. Following the sale, the director directly owned 20,795 shares in the company, valued at approximately $1,502,438.75. The trade was a 3.45% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Insiders own 1.80% of the company’s stock.

Analyst Ratings Changes

MMS has been the topic of several research analyst reports. Zacks Research cut Maximus from a “strong-buy” rating to a “hold” rating in a research report on Monday, April 27th. Wall Street Zen raised Maximus from a “hold” rating to a “buy” rating in a research report on Saturday, June 6th. Finally, Weiss Ratings cut Maximus from a “hold (c)” rating to a “hold (c-)” rating in a research report on Wednesday, May 20th. Two equities research analysts have rated the stock with a Hold rating, Based on data from MarketBeat, the company has a consensus rating of “Hold”.

Maximus Company Profile

Maximus, Inc (NYSE: MMS) is a global provider of government services focused on delivering health and human services programs. The company partners with federal, state, and local agencies to administer and manage programs that support individuals and families across various stages of life. Key service areas include eligibility determination and enrollment services for Medicaid, Medicare, Children’s Health Insurance Program (CHIP) and other public assistance programs, as well as call center operations, case management and program integrity solutions.